When talk about phase 2 and registration trial, recall few years back I don't remember which drug was that, FDA said it was unethical that IMU to keep the clinical trial, should push to complete or shorten the trial patient number? Where is that drug now? Dead end?
Ann: Azer-cel Hits Major Milestone in Phase 1b CAR T Trial, page-193
-
- There are more pages in this discussion • 50 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
